These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 3097416
21. Serum 17-hydroxypregnenolone and 17-hydroxypregnenolone sulfate concentrations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Shimozawa K, Saisho S, Yata J, Kambegawa A. Endocrinol Jpn; 1988 Feb; 35(1):11-8. PubMed ID: 3260857 [Abstract] [Full Text] [Related]
22. Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva. Hughes IA, Dyas J, Robinson J, Walker RF, Fahmy DR. Ann N Y Acad Sci; 1985 Feb; 458():193-202. PubMed ID: 3879122 [No Abstract] [Full Text] [Related]
28. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. I. Microfilter paper methods for radioimmunoassay of 17 alpha-hydroxyprogesterone]. Shimozawa K. Nihon Naibunpi Gakkai Zasshi; 1983 Dec 20; 59(12):1845-9. PubMed ID: 6609091 [Abstract] [Full Text] [Related]
29. Neonatal screening programme for congenital adrenal hyperplasia in a homogeneous Caucasian population. Cacciari E, Balsamo A, Cassio A, Piazzi S, Bernardi F, Salardi S, Cicognani A, Pirazzoli P, Zappulla F, Capelli M. J Inherit Metab Dis; 1986 Dec 20; 9 Suppl 1():142-6. PubMed ID: 3097413 [No Abstract] [Full Text] [Related]
30. [17-hydroxyprogesterone in blood dried on filter paper from healthy premature and term neonates and patients with congenital adrenal hyperplasia]. Zurga B, Dumić M, Plavsić V, Mardesić D, Vondracek M, Stefanović N. Lijec Vjesn; 1988 May 20; 110(5):136-40. PubMed ID: 3412101 [No Abstract] [Full Text] [Related]
32. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 2. Analysis of steroids with high-performance liquid chromatography for diagnosis of congenital adrenal hyperplasia]. Mizushima Y, Fukushi M, Arai O, Takasugi N, Fujieda K, Matsuura N, Fujimoto S. Nihon Naibunpi Gakkai Zasshi; 1987 Feb 20; 63(2):102-12. PubMed ID: 3494637 [Abstract] [Full Text] [Related]
34. Early diagnosis of 11 beta-hydroxylase deficiency in two siblings confirmed by analysis of a novel steroid metabolite in newborn urine. Hughes IA, Arisaka O, Perry LA, Honour JW. Acta Endocrinol (Copenh); 1986 Mar 20; 111(3):349-54. PubMed ID: 3515819 [Abstract] [Full Text] [Related]
35. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia. Sólyom J. Arch Dis Child; 1984 Aug 20; 59(8):743-7. PubMed ID: 6541026 [Abstract] [Full Text] [Related]
36. Pitfalls in prenatal diagnosis of 21-hydroxylase deficiency by amniotic fluid steroid analysis? A six years experience in 102 pregnancies at risk. Forest MG. Ann N Y Acad Sci; 1985 Aug 20; 458():130-47. PubMed ID: 3879118 [No Abstract] [Full Text] [Related]
37. Neonatal screening for congenital adrenal hyperplasia. Cacciari E, Balsamo A, Cassio A, Piazzi S, Bernardi F, Salardi S, Cicognani A, Pirazzoli P, Zappulla F, Capelli M. Arch Dis Child; 1983 Oct 20; 58(10):803-6. PubMed ID: 6639129 [Abstract] [Full Text] [Related]